๐Ÿ”Ž Trials Near Me

Home โ€บ Lymphoma

Lymphoma clinical trials recruiting in the U.S.

142 studies for Lymphoma are recruiting participants at sites across the United States.

Lymphoma is a cancer affecting the immune system. Hodgkins Lymphoma and Non Hodgkins Lymphoma are types of lymphoma. Learn about symptoms and treatments.

Cities with the most studies

By state

Recently updated studies

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

RecruitingPhase 1
Ages 12 to 75 ยท All sexes ยท Updated Oct 2, 2026 ยท NCT02917083

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

RecruitingPhase 2
Ages 12 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT03258567

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

RecruitingObservational study
Ages 3 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT01441089

Rutgers University Study of the Genetics of Blood Cancers

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 110 ยท All sexes ยท Updated Oct 1, 2026 ยท NCT07714044

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Oct 1, 2026 ยท NCT06343311

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RecruitingObservational study
Ages 0 to 38 ยท All sexes ยท Updated Oct 1, 2026 ยท NCT06131801

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

RecruitingPhase 1/2
Ages 3 to 39 ยท All sexes ยท Updated Sep 30, 2026 ยท NCT05442515

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 30, 2026 ยท NCT07192471

Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 29, 2026 ยท NCT07583810

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

RecruitingObservational study
Ages 18 to 120 ยท All sexes ยท Updated Sep 28, 2026 ยท NCT00006518

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07013435

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07014293

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT03418038

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

RecruitingPhase 1/2
Ages 18 to 120 ยท All sexes ยท Updated Sep 28, 2026 ยท NCT03223610

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

RecruitingPhase 1/2
Up to age 25 ยท All sexes ยท Updated Sep 25, 2026 ยท NCT04094610

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

RecruitingPhase 1
24 Months โ€“ 18 Years ยท All sexes ยท Updated Sep 25, 2026 ยท NCT06441331

Epco, Zanu, Ritux for R/R FL or MZL

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT06563596

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 24, 2026 ยท NCT02974647

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

RecruitingPhase 2
Ages 18 to 99 ยท All sexes ยท Updated Sep 24, 2026 ยท NCT04083495

Precise Oncology Interventions in Nutrition and Training (OnPoint)

RecruitingHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Sep 23, 2026 ยท NCT06534918

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.